Associate Professor Linda Gowing

Linda Gowing
Associate Professor
Adelaide Medical School
Faculty of Health and Medical Sciences

I am a Principal Research Officer with Drug and Alcohol Services South Australia, and an Associate Professor in the Discipline of Pharmacology.

I have been working in the area of evidence-based practice in the treatment of addiction since 1998. I have substantial experience in the preparation of systematic reviews, including Cochrane reviews, and evidence-based guidelines. I am the primary author of five Cochrane reviews, four on approaches to the management of opioid withdrawal, and one on substitution treatment of opioid dependence for prevention of HIV. I have also been a mentor for researchers in Thailand, China, USA and Australia, helping them to become familiar with the systematic review process and undertake their own Cochrane reviews on the treatment of alcohol and other drug use.

The dissemination of the findings of systematic reviews in a form that promotes adoption of the findings is another area of interest that has resulted in monographs on the effectiveness of interventions for illicit drug use and pharmacotherapies for relapse prevention treatment of alcohol dependence as well as journal articles on the management of opioid withdrawal. Most recently I was involved in revision of the national policy and guidelines on medication assisted treatment for opioid dependence in Australia.

I am also involved in teaching in the area of addiction, including through the International Program on Addiction Studies, and a Massive Online Open Course on Managing Addiction that was hosted on EdX in 2015.

Connect With Me

External Profiles

Associate Professor Linda Gowing

I am a Principal Research Officer with Drug and Alcohol Services South Australia, and an Associate Professor in the Discipline of Pharmacology.

I have been working in the area of evidence-based practice in the treatment of addiction since 1998. I have substantial experience in the preparation of systematic reviews, including Cochrane reviews, and evidence-based guidelines. I am the primary author of five Cochrane reviews, four on approaches to the management of opioid withdrawal, and one on substitution treatment of opioid dependence for prevention of HIV. I have also been a mentor for researchers in Thailand, China, USA and Australia, helping them to become familiar with the systematic review process and undertake their own Cochrane reviews on the treatment of alcohol and other drug use.

The dissemination of the findings of systematic reviews in a form that promotes adoption of the findings is another area of interest that has resulted in monographs on the effectiveness of interventions for illicit drug use and pharmacotherapies for relapse prevention treatment of alcohol dependence as well as journal articles on the management of opioid withdrawal. Most recently I was involved in revision of the national policy and guidelines on medication assisted treatment for opioid dependence in Australia.

I am also involved in teaching in the area of addiction, including through the International Program on Addiction Studies, and a Massive Online Open Course on Managing Addiction that was hosted on EdX in 2015.

Eligible to supervise Masters and PhD (as Co-Supervisor) — email supervisor to discuss availability.

Appointments

Date Position Institution name
2013 Affiliate Graduate Faculty Member Virginia Commonwealth University
2003 Associate Professor University of Adelaide
1998 - 2008 Lecturer, Level B Flinders University
1998 - 2004 Honorary Visiting Fellow University of New South Wales

Education

Date Institution name Country Title
1987 Australian National University Australia PhD
1982 Massey University New Zealand Bachelor of Science with First Class Honours

Research Interests

Journals

Year Citation
2017 Saulle, R., Vecchi, S., & Gowing, L. (2017). Supervised dosing with a long-acting opioid medication in the management of opioid dependence. Cochrane Database of Systematic Reviews, 2017(4), 47 pages.
DOI Scopus1
2017 Gowing, L., Ali, R., & White, J. (2017). Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database of Systematic Reviews, 2017(5), 55 pages.
DOI Scopus3
2017 Gowing, L., Ali, R., White, J., & Mbewe, D. (2017). Buprenorphine for managing opioid withdrawal. Cochrane Database of Systematic Reviews, 2017(2), 1-95.
DOI Scopus54 WoS3 Europe PMC6
2016 Nielsen, S., Larance, B., Degenhardt, L., Gowing, L., Kehler, C., & Lintzeris, N. (2016). Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database of Systematic Reviews, 2016(5), CD011117-1-CD011117-17.
DOI Scopus33 WoS28 Europe PMC12
2016 Gates, P., Sabioni, P., Copeland, J., Le Foll, B., & Gowing, L. (2016). Psychosocial interventions for cannabis use disorder. Cochrane Database of Systematic Reviews, 2016(5), CD005336-1-CD005336-132.
DOI Scopus24 WoS7 Europe PMC4
2016 Gowing, L., Farrell, M., Ali, R., & White, J. (2016). Alpha<inf>2</inf>-adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews, 2016(5), 88 pages.
DOI Scopus39 WoS15 Europe PMC7
2015 Gowing, L., & West, R. (2015). Reply to Warnakulasuriya et al.. Addiction, 110(9), 1533-1534.
DOI
2015 Cusack, L., Kelly, J., Harland, J., Gowing, L., Grønkjaer, M., & Whitaker, N. (2015). Alcohol and drug screening for older Australians. Australian Nursing and Midwifery Journal, 22(7), 41.
2015 Gowing, L., Ali, R., Allsop, S., Marsden, J., Turf, E., West, R., & Witton, J. (2015). Global statistics on addictive behaviours: 2014 status report. Addiction, 110(6), 904-919.
DOI Scopus78 WoS72 Europe PMC50
2015 Gowing, L. (2015). Identifying corrections-is there a better way?. Addiction, 110(7), 1207.
DOI
2014 Marshall, K., Gowing, L., Ali, R., & Le Foll, B. (2014). Pharmacotherapies for cannabis dependence. The Cochrane database of systematic reviews, 12(12), CD008940.
DOI Scopus53 WoS20 Europe PMC14
2014 Gowing, L., Farrell, M., Ali, R., & White, J. (2014). Alpha2-adrenergic agonists for the management of opioid withdrawal (review). The Cochrane database of systematic reviews, 2014(3), CD002024-1-CD002024-87.
DOI Scopus19 WoS6 Europe PMC10
2014 Larney, S., Gowing, L., Mattick, R., Farrell, M., Hall, W., & Degenhardt, L. (2014). A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence. Drug and Alcohol Review, 33(2), 115-128.
DOI Scopus8 WoS8 Europe PMC5
2014 Nielsen, S., Degenhardt, L., Larance, B., Gowing, L., Kehler, C., & Lintzeris, N. (2014). Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database of Systematic Reviews, 2014(5).
DOI Scopus9
2013 Gowing, L., Hickman, M., & Degenhardt, L. (2013). Mitigating the risk of HIV infection with opioid substitution treatment. Bulletin of the World Health Organization, 91(2), 148-149.
DOI Scopus15 WoS16 Europe PMC11
2013 Rees, E., & Gowing, L. (2013). Supplementary thiamine is still important in alcohol dependence. Alcohol and Alcoholism, 48(1), 88-92.
DOI Scopus19 WoS13 Europe PMC9
2012 Farrell, M., Wodak, A., & Gowing, L. (2012). Maintenance drugs to treat opioid dependence. BMJ (Online), 344(7859), 1-5.
DOI Scopus21 WoS15 Europe PMC8
2012 Pan, S., Gowing, L., Li, C., & Zhao, M. (2012). Contingency management for substance use disorders (Protocol). The Cochrane Database of Systematic Reviews, 8, 1-13.
DOI
2012 Gowing, L. (2012). The role of opioid substitution treatment in reducing HIV transmission: risks for drug users and the wider community are substantially reduced. BMJ, 345(7879), e6425-1-e6425-2.
DOI Scopus3 WoS2 Europe PMC1
2011 Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2011). Oral substitution treatment of injecting opioid users for prevention of HIV infection (Review). The Cochrane Database of Systematic Reviews, (8), 004145-1-004145-116.
DOI Scopus117 WoS92 Europe PMC30
2011 Gowing, L., Marshall, K., & Ali, R. (2011). Pharmacotherapies for cannabis withdrawal. Cochrane Database of Systematic Reviews, (1).
DOI
2010 Gowing, L., Ali, R., & White, J. (2010). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. The Cochrane Database of Systematic Reviews, (1), 28 pages.
DOI Scopus18 WoS3
2009 Gowing, L., Ali, R., & White, J. (2009). Buprenorphine for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (3), 38 pages.
DOI Scopus31 WoS32 Europe PMC7
2009 Gowing, L., Ali, R., & White, J. (2009). Opioid antagonists with minimal sedation for opioid withdrawal. The Cochrane Database of Systematic Reviews, 2009(4), 1-47.
DOI Scopus17 WoS12 Europe PMC6
2009 Gowing, L., Ali, R., & White, J. (2009). Buprenorphine for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, 2009(3), 1-76.
DOI Scopus70 WoS44 Europe PMC18
2009 Gowing, L., Farrell, M., Ali, R., & White, J. (2009). Alpha₂-adrenergic agonists for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, Online(2), 1-87.
DOI Scopus45 WoS32 Europe PMC7
2009 Ali, R., Burrows, D., Gowing, L., Vial, R., Walsh, N., Onyancha, P., & Finnerty, E. (2009). Review of Global Policy Architecture and Country Level Practice on HIV/AIDS and Drug Treatment.
2008 Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2008). Substitution treatment of injecting opioid users for prevention of HIV infection. The Cochrane Database of Systematic Reviews, 2009(2), 1-102.
DOI Scopus89 Europe PMC25
2006 Gowing, L., Ali, R., & White, J. (2006). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal (review). The Cochrane Database of Systematic Reviews, Online(Issue 2. Art. No. CD002022), 1-26.
DOI Scopus33 WoS19 Europe PMC8
2006 Gowing, L., & Ali, R. (2006). The place of detoxification in treatment of opioid dependence. Current Opinion in Psychiatry, 19(3), 266-270.
DOI Scopus21 WoS12 Europe PMC8
2006 Gowing, L., Ali, R., & White, J. (2006). Opioid antagonists with minimal sedation for opioid withdrawal (review). The Cochrane Database of Systematic Reviews, Online(1AR CD002021DI ARTN CD002021), 2021.
DOI Scopus14 WoS4
2006 Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2006). Methadone treatment of injecting opioid users for prevention of HIV infection. Journal of General Internal Medicine (online), 21(2), 193-195.
DOI Scopus68 WoS61 Europe PMC42
2005 Farrell, M., Gowing, L., Marsden, J., Ling, W., & Ali, R. (2005). Effectiveness of drug dependence treatment in HIV prevention. International Journal of Drug Policy, 16S(SUPPL. 1), S67-S75.
DOI Scopus46 WoS34
2004 Gowing, L., Farrell, M., Ali, R., & White, J. (2004). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online : Update Software), (4), 45 pages.
DOI Scopus15 WoS9 Europe PMC7
2004 Kaya, C., Tugai, Y., Filar, J., Agrawal, M., Ali, R., Gowing, L., & Cooke, R. (2004). Heroin users in Australia: population trends. Drug and Alcohol Review, 23(1), 107-116.
DOI Scopus13 Europe PMC1
2004 Gowing, L., Ali, R., & White, J. (2004). Buprenorphine for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (4), CD002025.
DOI Scopus27 Europe PMC2
2004 Amato, L., Davoli, M., Ferri, M., Gowing, L., & Perucci, C. (2004). Effectiveness of interventions on opiate withdrawal treatment: An overview of systematic reviews. Drug and Alcohol Dependence, 73(3), 219-226.
DOI Scopus64 Europe PMC35
2004 Gowing, L., Farrell, M., Bornemann, R., & Ali, R. (2004). Substitution treatment of injecting opioid users for prevention of HIV infection. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (4), 61 pages.
DOI WoS9
2004 Gowing, L., Farrell, M., Bornemann, R., & Ali, R. (2004). Substitution treatment of injecting opioid users for prevention of HIV infection.. Cochrane database of systematic reviews (Online), (4), CD004145.
DOI Scopus34 Europe PMC2
2004 Gowing, L., & Lopatko, O. (2004). Office based treatment with buprenorphine plus naloxone, or buprenorphine alone reduces opiate use and craving: Commentary. Evidence-Based Mental Health, 7(2), 54.
DOI Scopus1 Europe PMC1
2004 Shearer, J., & Gowing, L. (2004). Pharmacotherapies for problematic psychostimulant use: A review of current research. Drug and Alcohol Review, 23(2), 203-211.
DOI Scopus36 Europe PMC19
2003 Gowing, L., Farrell, M., Ali, R., & White, J. (2003). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (2), CD002024.
DOI Scopus2 Europe PMC1
2003 Ali, R., Thomas, P., White, J., McGregor, C., Danz, C., Gowing, L., . . . Athanasos, P. (2003). Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity. Drug and Alcohol Review, 22(4), 425-431.
DOI Scopus8 WoS8 Europe PMC5
2002 Gowing, L., Henry-Edwards, S., Irvine, R., & Ali, R. (2002). The health effects of ecstacy: a literature review. Drug and Alcohol Review, 21(1), 53-63.
DOI Scopus104 Europe PMC62
2002 Gowing, L., Ali, R., & White, J. (2002). Which substitution pharmacotherapy is most effective in treating opioid dependence?. Medical Journal of Australia, 176(10), 493-494.
2002 Gowing, L., Farrell, M., Ali, R., & White, J. (2002). a₂-Adrenergic agonists in opioid withdrawal. Addiction, 97(1), 49-58.
DOI Scopus58 WoS43 Europe PMC41
2002 McGregor, C., Ali, R., White, J., Thomas, P., & Gowing, L. (2002). A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months. Drug and Alcohol Dependence, 68(1), 5-14.
DOI Scopus32 WoS31 Europe PMC20
2002 Gowing, L., Ali, R., & White, J. (2002). Buprenorphine for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, (2), CD002025-1-CD002025-22.
DOI Scopus13 Europe PMC2
2002 Gowing, L., Henry-Edwards, S., Irvine, R., & Ali, R. (2002). The health effects of ecstasy: a literature review. DRUG AND ALCOHOL REVIEW, 21(1), 53-63.
DOI WoS81
2002 Gowing, L., Ali, R., & White, J. (2002). Buprenorphine for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (2), CD002025.
DOI Scopus20 Europe PMC3
2002 Gowing, L., Ali, R., & White, J. (2002). Opioid antagonists with minimal sedation for opioid withdrawal.. Cochrane database of systematic reviews (Online : Update Software), (2), CD002021.
DOI Scopus11 Europe PMC2
2002 Gowing, L., Ali, R., & White, J. (2002). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.. Cochrane database of systematic reviews (Online), (2), CD002022.
DOI Scopus7 Europe PMC2
2001 Gowing, L., Farrell, M., Ali, R., & White, J. (2001). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (1), CD002024.
DOI Scopus8 Europe PMC3
2001 Gowing, L., Ali, R., & White, J. (2001). Opioid antagonists under sedation or anaesthesia for opioid withdrawal.. Cochrane database of systematic reviews (Online), (1), CD002022.
DOI Scopus5
2001 Gowing, L., Ali, R., & White, J. (2001). Buprenorphine for the management of opioid withdrawal. Praxis, 90(44), 1934.
2000 Gowing, L., Ali, R., & White, J. (2000). Opioid antagonists and adrenergic agonists for the management of opioid withdrawal. Praxis, 89(44), 1810-1811.
2000 Gowing, L., Ali, R., & White, J. (2000). Opioid antagonists and adrenergic agonists for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, (2), 1-2.
DOI Scopus10 Europe PMC2
2000 Gowing, L., Ali, R., & White, J. (2000). The management of opioid withdrawal. Drug and Alcohol Review, 19(3), 309-318.
DOI Scopus15 WoS13
2000 Gowing, L., Ali, R., & White, J. (2000). Systematic review processes and the management of opioid withdrawal. Australian and New Zealand Journal of Public Health, 24(4), 427-431.
DOI Scopus3 WoS2 Europe PMC1
1998 Gowing, L., Ali, R., Christie, P., & White, J. (1998). Therapeutic use of cannabis: clarifying the debate. Drug and Alcohol Review, 17(4), 445-452.
DOI WoS2 Europe PMC1
1985 Gowing, L., Tellam, R., & Banyard, M. (1985). Actin synthesis in tumorigenic and non-tumorigenic human hybrid cells. Journal of Cell Science, 76, 255-267.
Scopus3 Europe PMC1
1984 Robertson, J., Thomas, J., Gowing, L., & Boland, M. (1984). Mg2+ Adenosine Triphosphatase from Cell Envelopes of Free-Living and Bacteroid Forms of Rhizobium lupini Strain NZP2257. Archives of Biochemistry and Biophysics, 232(1), 337-347.
DOI Scopus2 Europe PMC2
1984 Gowing, L., Tellam, R., & Banyard, M. (1984). Microfilament organization and total actin content are decreased in hybrids derived from the fusion of HeLa Cells with human fibroblasts. Journal of Cell Science, 69, 137-146.
Scopus9 Europe PMC7

Books

Year Citation
2014 Gowing, L., Ali, R., Dunlop, A., Farrell, M., & Lintzeris, N. (2014). National Guidelines for Medication-Assisted Treatment of Opioid Dependence. Commonwealth of Australia, Canberra.

Book Chapters

Year Citation
2016 Ali, R., Gowing, L., & Harland, J. (2016). The Ultrarapid Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST-Lite) and Implications for Neuropathology. In V. Preedy (Ed.), Neuropathology of Drug Addictions and Substance Misuse, Volume 1: Foundations of Understanding, Tobacco, Alcohol, Cannabinoids and Opioids (Vol. 1, pp. 649-659). United Kingdom: Elsevier.
DOI
2015 Ali, R., Gowing, L. R., & Harland, J. (2015). Screening and brief interventions. In P. Haber, C. Day, & M. Farrell (Eds.), Addiction Medicine: Principles and Practice (pp. 126-142). Melbourne: IP Communications.
2009 Lintzeris, N., Gowing, L., & Bell, J. (2009). Services for heroin withdrawal: A review. In R. P. Mattick, R. Ali, & N. Lintzeris (Eds.), Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines (pp. 54-106). New York, USA: Informa.
2009 Lintzeris, N., Clark, N., Muhleisen, P., Ritter, A., Ali, R., Bell, J., . . . White, J. (2009). National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence. In R. P. Mattick, R. Ali, & N. Lintzeris (Eds.), Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines (pp. 390-445). New York, USA: Informa.
2009 Henry-Edwards, S., Gowing, L., White, J., Ali, R., Bell, J., Brough, J., . . . Quigley, A. (2009). Clinical guidelines and procedures for the use of methadone in the maintenance treatment of opioid dependence. In R. P. Mattick, R. Ali, & N. Lintzeris (Eds.), Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines (pp. 354-389). New York, USA: Informa.

Conference Papers

Year Citation
2016 Gates, P., Sabioni, P., Copeland, J., Le Foll, B., & Gowing, L. (2016). Psychosocial interventions for cannabis use disorder. In Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference 2016, as published in Drug and Alcohol Review Vol. 35 (pp. 37). Sydney, Australia: Wiley.
DOI
2014 ali, R., & Gowing, L. (2014). Translating evidence into the best outcomes in addiction treatment. In CJAM Canadian Journal of Addiction Medicine Vol. 5 (pp. 20). Canadian Society of Addiction Medicine.

Conference Items

Year Citation
2016 Gowing, L., & Larney, S. (2016). SUSTAINED-RELEASE PREPARATIONS OF NALTREXONE FOR THE TREATMENT OF ALCOHOL AND OPIOID DEPENDENCE: CURRENT STATUS. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY.
2012 Gowing, L. (2012). MEDICATIONS FOR ALCOHOL DEPENDENCE: MECHANISMS, EFFECTIVENESS AND FUTURE DIRECTIONS. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY-BLACKWELL.
2012 Rees, E., & Gowing, L. (2012). Thiamine in alcohol dependence. Poster session presented at the meeting of Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference 2012, as published in Drug and Alcohol Review. Melbourne, Victoria: Wiley-Blackwell.
DOI
2012 Ali, R., & Gowing, L. (2012). SYMPOSIUM - NATIONAL POLICY AND GUIDELINES FOR THE PHARMACOLOGICAL TREATMENT OF OPIOID DEPENDENCE. Poster session presented at the meeting of DRUG AND ALCOHOL REVIEW. WILEY-BLACKWELL.

Recorded/Rendered Creative Works

Year Citation
2015 Publication status: Published
NTRO sub category: 4 Digital creative work
Title: Managing Addiction: A Framework for Successful Treatment
Authors: Buisman-Pijlman FT, Gowing L, Ali R, Salem A
Publisher: EdX
Publisher URL: https://www.edx.org/
Place of publication: YouTube
Publication date: 2015
Extent: 5 week course
Abstract: EdX keeps courses open for enrollment after they end to allow learners to explore content and continue learning. All features and materials may not be all available. Check back often to see when new course start dates are announced.

Addiction is such a common problem today that clients experiencing alcohol, nicotine or other drug problems present in many different healthcare settings. The challenge of identifying effective ways to help people experiencing addiction is a serious one, and much depends on the quality of the clinical decisions we make. This course is intended to help you meet this challenge by increasing your understanding of the biology of addiction and the available treatment options in the different stages of the recovery journey.

Key questions we will look at in this course include:

Why is it so difficult to change addictive behaviour?
What kinds of treatment can help a person experiencing addiction?
What is my role as a professional, either within or outside of addiction care?
How can I identify the best of the many options available?
What evidence do I need to be able to make a sound decision about treatment?
What approaches to addiction are proven to work around the world?
What is the potential impact of my decisions on the life of a person experiencing addiction?
This course explores the “Recovery Pathway,” an easy-to-use framework for helping people with addiction move successfully from addiction to recovery. It will help you to plan a pathway through screening and assessment, to withdrawal and long-term relapse prevention. It will examine a range of psychosocial interventions and medication-assisted treatments. At each step of the pathway, you will review the biological basis of behaviour and treatment as well as evidence-based and service delivery considerations. It is an ideal starting-point for healthcare professionals who want to get to grips with potentially effective approaches to treating addiction, and need tools to make critical decisions.
Keywords: addiction, Treatment, Mental Health, Online course
Record created at source: 30 June 2016

Current Higher Degree by Research Supervision (University of Adelaide)

Date Role Research Topic Program Degree Type Student Load Student Name
2018 Co-Supervisor A Systematic Review of Screening Approaches for Alcohol and Other Drugs in Health Care Settings Master of Philosophy (Clinical Science) Master Full Time Dr Sonali Meena

Editorial Boards

Date Role Editorial Board Name Institution Country
2012 - ongoing Board Member Cochrane Collaboration Drugs and Alcohol Group
2005 - ongoing Associate Editor Addiction
2001 - 2012 Associate Editor Cochrane Collaboration Drugs and Alcohol Group
Position
Associate Professor
Phone
83138055
Campus
North Terrace
Building
Helen Mayo South Building, floor 5
Room Number
5 11b
Org Unit
Medical Sciences

top